Checked.be
Active
BE 0726.900.578Private limited company
DR. SOFIE DE MUNTER
Bouchoutstraat 17 ·9250 Waasmunster, Belgium· 7 yrs active
Sector: General medical practice
(86210)
Conclusion
DR. SOFIE DE MUNTER has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €5k and a net result of €80k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 15% of 16012 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Based on the State Gazette, CBE and 5 annual accounts.
Key figures
| Equity | €5k |
| Net result | €80k |
| Better than sector | 15% |
| Active | 7 yrs |
Financial profile
71
/ 100
Strong profile, led by profitability.
All 5 axes are computed from data Checked has read.
Health
73
Profitability
100
Solvency
25
Growth
58
Stability
100
Bankruptcy probability (12 mo)
Risk Assessment
0 / 100
Low riskTrust signals
More than 3 years active
Founded in 2019, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Checked score
73
/ 100
Healthy
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
Indicative credit limit
€500
estimate, not credit advice
Score history
93
2021
65
2022
73
2023
73
2024
73
2025
purely financial, excl. current insolvency signals
Score components
Liquidity
Current ratio 1.28 (≥ 1.0)
+5
Quick ratio
Quick ratio 1.28 (≥ 1.0)
+5
Leverage
Debt/equity 8.02 (> 3.0)
-10
Profitability
ROE 1604% (≥ 10%)
+10
Interest coverage
Interest coverage 72.4× (≥ 3×)
+8
Profit trend
Net profit up YoY
+5
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.
Financial overview
Annual accounts filed on 28-05-2026 with the NBB · fiscal year 2025 · micro schema
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing
Net result: growth of ~8.9%/year over 5 fiscal years, indicative, assuming unchanged policy.
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
Sector comparison
Fiscal year 2025 · NACE 86, Human health activities · compared within the same schema type (micro schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 11.1% | 63.4% | |
| Net result | €80k | €62k | |
| Equity | €5k | €132k | |
| Gross operating margin | €107k | €116k | |
| Total assets | €45k | €286k |
€105k
-0.7%
21-25
€80k
+0.1%
21-25
€82k
0.0%
21-25
€45k
-57.6%
21-25
€5k
0.0%
21-25
€9k
+18.2%
21-25
€22k
-0.4%
21-25
€80k
+0.1%
21-25
€40k
-60.5%
21-25
€33k
-64.8%
21-25
1.28
+18.2%
21-25
1.28
+18.2%
21-25
11.1%
+136.0%
21-25
8.02
-60.5%
21-25
1603.8%
+0.1%
21-25
177.8%
+136.1%
21-25
72.40
+40.9%
21-25
Figures by fiscal year and ratios
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Deposit | micro schema | micro schema | micro schema | micro schema | micro schema |
| Revenue | - | - | - | - | - |
| EBITDA | €105k | €106k | €81k | €60k | €90k |
| Net profit | €80k | €80k | €62k | €45k | €70k |
| Cash flow | €82k | €82k | €63k | €45k | €71k |
| Staff costs | - | - | - | - | - |
| Income taxes | €22k | €22k | €17k | €13k | €18k |
| Dividends | €80k | €80k | €79k | €144k | €25k |
| Total assets | €45k | €106k | €106k | €162k | €159k |
| Equity | €5k | €5k | €5k | €22k | €121k |
| Debt | €40k | €101k | €101k | €140k | €38k |
| of which ≤ 1y | €33k | €95k | €91k | €128k | €32k |
| of which > 1y | - | - | - | - | - |
| Working capital | €9k | €8k | €9k | €33k | €124k |
| Employees (FTE) | - | - | - | - | - |
Ratios (computed)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Current ratio | 1.28 | 1.08 | 1.10 | 1.26 | 4.88 |
| Quick ratio | 1.28 | 1.08 | 1.10 | 1.26 | 4.88 |
| Working capital ratio | 20.7% | 7.4% | 8.3% | 20.5% | 77.8% |
| Solvency | 11.1% | 4.7% | 4.7% | 13.8% | 76.0% |
| Debt / equity | 8.02 | 20.29 | 20.11 | 6.26 | 0.32 |
| Long-term debt ratio | - | - | - | - | - |
| Interest coverage | 72.40 | 51.37 | 48.53 | 43.84 | 60.73 |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| ROA | 177.8% | 75.3% | 58.7% | 27.6% | 44.0% |
| ROE | 1603.8% | 1602.9% | 1238.1% | 200.7% | 57.9% |
| EBITDA margin | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - |
| Days inventory (DSI) | - | - | - | - | - |
Balance-sheet composition 2025
Full annual accounts (23 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Balance sheet, Assets | ||||||
| TOTAL ASSETS | 20/58 | €45k | €106k | €106k | €162k | €159k |
| Fixed assets | 21/28 | €2k | €4k | €5k | €367 | €3k |
| Tangible fixed assets | 22/27 | €2k | €4k | €5k | €367 | €955 |
| Financial fixed assets | 28 | - | - | - | - | €3k |
| Current assets | 29/58 | €43k | €103k | €100k | €162k | €156k |
| Amounts receivable within one year | 40/41 | €937 | €1k | €2k | €4k | €3k |
| Cash & bank | 54/58 | €32k | €97k | €90k | €150k | €147k |
| Balance sheet, Equity & liabilities | ||||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €45k | €106k | €106k | €162k | €159k |
| Equity | 10/15 | €5k | €5k | €5k | €22k | €121k |
| Contributions / capital | 10/11 | €5k | €5k | €5k | €5k | €5k |
| Reserves | 13 | - | - | €0 | €17k | €116k |
| Accumulated profits (losses) | 14 | €0 | €0 | €0 | - | - |
| Amounts payable | 17/49 | €40k | €101k | €101k | €140k | €38k |
| Amounts payable within one year | 42/48 | €33k | €95k | €91k | €128k | €32k |
| Trade debts payable within one year | 44 | €1k | €234 | €239 | €683 | €547 |
| Income statement | ||||||
| Gross operating margin | 9900 | €107k | €107k | €82k | €61k | €91k |
| Operating result | 9901 | €104k | €104k | €80k | €59k | €90k |
| Financial income | 75 | - | - | €0 | €3 | - |
| Financial charges | 65 | €1k | €2k | €2k | €1k | €1k |
| Result before taxes | 9903 | €102k | €102k | €79k | €58k | €88k |
| Income taxes | 67/77 | €22k | €22k | €17k | €13k | €18k |
| Net result for the period | 9904 | €80k | €80k | €62k | €45k | €70k |
| Result to be appropriated | 9905 | €80k | €80k | €62k | €45k | €70k |
Legal Structure
| NACE primary | General medical practice(86210) |
| Legal form | Private limited company(610) |
| Incorporation | 20-05-2019 |
| Status | Active |
| Postal code | 9250 |
Establishment units
DR. SOFIE DE MUNTER
since 20192.289.451.012
DR. SOFIE DE MUNTER
since 20192.289.451.111
Real-estate footprint
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 42342C0300/00_000 | Flanders | 8,160 m² | - | - |
| 42023A1563/00E002 | Flanders | 1,839 m² | 1 · 158 m² | 9.2 m · 2 fl. |
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates
Next filing, fiscal year 2026, expected by
2026
28-05
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2021net €80k ▲0.1%
Net result €80k, the highest in the series.
01-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
01-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
22-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Weakest financial yearnet €45k ▼36.1%
Net result drops to €45k, the lowest in the series; recovery starts the following year.
30-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
06-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
09-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Belgian State Gazette reading coverage
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Credit advice
Company registry (CBE)
Activities
General medical practice86210
Names & trade names
| Legal nameNL | DR. SOFIE DE MUNTER |
Similar companies
DR AN BEECKMAN, Huisarts
BE 0645.830.651 · Ninove
Dr.Brigitte DE GEYTER Algemene Geneeskunde
BE 0674.645.688 · Waterloo
Dokterspraktijk DBE
BE 0728.453.172 · Oudenaarde
Dr.Pieter Boudt, huisarts
BE 0728.743.875 · Gent
DR. Lieve Mertens
BE 0729.519.380 · Lint